Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

Is There a Risk of Cannabis Use Disorder (CUD) When Treating Depression? 

Posted
Updated
ByMy Patient Advice
Author: Dr. Clarissa Morton, PharmD

When considering cannabis for mental health, one concern is the possibility of developing cannabis use disorder. This condition involves difficulty controlling use despite negative effects on wellbeing or daily life. For people with depression, the risk may be higher, as cannabis is sometimes used to self-manage symptoms like low mood or poor sleep. 

Researchers note that while not everyone who uses cannabis will develop cannabis use disorder, the risk is greater with frequent, high-THC products. This highlights the importance of medical guidance and structured monitoring. 

Is Medical Cannabis Legal in UK?

Understanding The Risks 

Studies exploring cannabis use disorder in depression often emphasise the importance of recognising early warning signs. Below are some of the factors most commonly linked to this condition. 

Dependence Risk 

Regular use can lead to a dependence risk, where individuals feel they need cannabis to cope. This may interfere with recovery from depression and reduce the effectiveness of other treatments. 

Problematic Use 

Some people develop patterns of problematic use, such as neglecting responsibilities or experiencing conflict due to cannabis consumption. These behaviours may worsen the social and emotional difficulties already present in depression. 

Addiction Potential 

Research also highlights an addiction potential with prolonged, heavy use. While not as addictive as some other substances, cannabis can still lead to cravings, withdrawal symptoms, and impaired control. 

In summary, the possibility of developing cannabis use disorder is an important consideration in depression care. Patients should be aware of risks alongside potential benefits, particularly when using cannabis regularly. 

For those concerned about safe use and dependency risks, providers like LeafEase can offer confidential consultations to guide responsible treatment choices. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Depression.

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories